Genetic Analysis of the β-Adrenergic Receptor

  • Catherine D. Strader
  • Richard A. F. Dixon
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 287)


Perhaps the largest class of hormone and neurotransmitter receptors is those whose signal transduction pathways involve the activation of guanine nucleotide binding regulatory proteins (G-proteins). Hormones which activate such receptors are prevalent in both the central nervous system and the periphery, and include glycoproteins (lutropin, thyrotropin), peptides (neurokinins, angiotensin), and small molecules (retinal, biogenic amines). The signal tranduction pathway common to these systems is initiated by the binding of the ligand to the cell-surface receptor. The agonist-bound receptor interacts with a G-protein, forming a high-affinity ternary hormone-receptor-G-protein complex, and catalyzing the exchange of GDP for GTP in the nucleotide binding site of the G-protein (Gilman, 1987). This nucleotide exchange reaction activates the G-protein and destabilizes the ternary complex. The activated G-protein then interacts with effector systems, leading to the modulation of intracellular second messenger levels. Effector systems which are activated by G-protein coupled pathways include adenylyl cyclase, guanylyl cyclase, phospholipases A and C, phosphodiesterases, Ca++ and K+ channels, and ion co-transport systems.


Adenylyl Cyclase Transmembrane Helix Intracellular Loop Wasp Venom Deletion Mutagenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aoki, C., Zemcik, B.A., Strader, C.D., and Pickel, V.M., 1990, Cytoplasmic loop of -adrenergic receptors: synaptic and intracellular localization and relation to catecholaminergic neurons in the nuclei of the solitary tracts. Brain Res., in press.Google Scholar
  2. Benovic, J.L., Strasser, R.H., Benovic, J.L., Daniel, K., and Lefkowitz, R.J., 1986, Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. (USA), 83:2797–2801.CrossRefGoogle Scholar
  3. Benovic, J.L., Kuhn, H., Weyand, I., Codina, J., Caron, M.G., and Lefkowitz, R.J., 1987, Functional desensitization of the isolated -adrenergic receptor by the -adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein)., Proc. Natl. Acad. Sci. (USA), 84:8879–8882.PubMedCrossRefGoogle Scholar
  4. Bouvier, M.W., Hausdorff, A, DeBlasi, A., O-Dowd, B.F., Kobilka, B.K., Caron, M.G., and Lefkowitz, R.J., 1988, Removal of phosphorylation sites from the -adrenergic receptor delays the onset of agonist-promoted desensitization. Nature, 333:370–373.PubMedCrossRefGoogle Scholar
  5. Cheung, A.H., Sigal, I.S., Dixon, R.A.F., and Strader, C.D., 1989, Agonist-promoted sequestration of the 2-adrenergic receptor requires regions involved in functional coupling with Gs. Mol. Pharm., 34:132–138.Google Scholar
  6. Cheung, A.H., Dixon, R.A.F., Hill, W.S., Sigal, I.S., and Strader, C.D., 1990, Separation of the structural requirements for agonist-promoted activation and sequestration of the -adrenergic receptor. Mol. Pharm, in press.Google Scholar
  7. Clark, R.B., Kunkel, M.W., Friedman, J., Goka, T.J., and Johnson, J. A, 1988, Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. Proc. Natl. Acad. Sci. (USA), 85:1442–1446.CrossRefGoogle Scholar
  8. Clark, R.B., Friedman, J, Dixon, R.A.F., and Strader, C.D., 1989, Identification of a specific site required for rapid heterologous desensitization of the -adrenergic receptor by cAMP-dependent protein kinase., Mol. Pharm, 36:343–348.Google Scholar
  9. Dixon, R.A.F., Sigal, I.S., Rands, E., Register, R.B., Candelore, M.R., Blake, A.D., and Strader, C.D., 1987a, Ligand binding to the -adrenergic receptor involves its rhodopsin-like core. Nature, 326:73–77.PubMedCrossRefGoogle Scholar
  10. Dixon, R.A.F., Sigal, I.S., Candelore, M.R., Register, R.B., Scattergood, W., Rands, E., and Strader, C.D., 1987b, Structural features required for ligand binding to the -adrenergic receptor. EMBO J, 6:3269–3275.Google Scholar
  11. Dixon, R.A.F., Sigal, I.S., and Strader, C.D., 1988, Structure-function analysis of the -adrenergic receptor. Cold Spring Harbor Symp. Quant. Biol., 53:487–489.PubMedCrossRefGoogle Scholar
  12. Dixon, R.A.F., Hill, W.S., Candelore, M.R., Rands, E., Diehl, R.E., Marshall, M.S., Sigal, I.S. and Strader, CD. (1989) Genetic analysis of the molecular basis for -adrenergic receptor subtype specificity. Proteins: Structure, Function, and Genetics, 6:267–274.CrossRefGoogle Scholar
  13. Findlay, J.B.C. and Pappin, D.J.C., 1986, The opsin family of proteins. Biochem. J, 238:625–642.PubMedGoogle Scholar
  14. Frielle, T., Daniel, K.W., Caron, M.G., and Lefkowitz, R.J., 1988, Structural basis of -adrenergic receptor subtype specificity studied with chimeric 1/2-adrenergic receptors. Proc. Natl. Acad. Sci. (USA), 85:9494–9498.CrossRefGoogle Scholar
  15. Gilman, A.G., 1987, G-proteins: transducers of receptor-generated signals. Ann. Rev. Biochem., 56:615–624.PubMedCrossRefGoogle Scholar
  16. Hamm, H.E., Deretic, D., Arendt, A, Hargrave, P.A., Koenig, B., and Hofmann, K.P., 1988, Site of G protein binding to rhodopsin mapped with synthetic peptides to the subunit.Science241:832–835.PubMedCrossRefGoogle Scholar
  17. Higashijima, T., Uzu, S., Nakajima, T., and Ross, E.M., 1988, Mastoparan, a peptide from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G-proteins). J. Biol. Chem, 262:6491–6494.Google Scholar
  18. Kobilka, B.K., MacGregor, C., Daniel, K., Kobilka, T.S., Caron, M.G., and Lefkowitz, R.J., 1987, Functional activity and regulation of human 2-adrenergic receptors expressed in Xenopus oocytes. J. Biol. Chem., 262:15796–15802.PubMedGoogle Scholar
  19. Kubo, T., Bujo, H., Akiba, I., Nakai, J., Mishina, M., and Numa, S., 1988, Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling. FEBS Lett., 241:119–125.PubMedCrossRefGoogle Scholar
  20. Kunkel, M.W., Friedman, J., Shenolikar, S., and Clark, R.B., 1989, Cell-free heterologous desensitization of adenylyl cyclase in S49 lymphoma cell membranes mediated by cAMP-dependent protein kinase. FASEB J3:2067–2074.Google Scholar
  21. Kwatra, M.M., Benovic, J.L, Caron, M.G., Lefkowitz, R. J., and Hosey, M.M., 1989, Phosphorylation of chick heart muscarinic cholinergic receptors by the -adrenergic receptor kinase., Biochemistry, 28:4543–4547.PubMedCrossRefGoogle Scholar
  22. O’Dowd, B.F., Hnatowich, M., Regan, J.W., Leader, W.M., Caron, M.G., and Lefkowitz, R.J., 1988, Site-directed mutagenesis of the cytoplasmic domains of the human 2-adrenergic receptor. J. Biol. Chem., 263:15985–15992.Google Scholar
  23. Palczewski, K., McDowell, J.H., and Hargrave, P.A., 1988, Rhodopsin kinase: substrate specificity and factors that influence activity. Biochemistry, 27:2306–2313.PubMedCrossRefGoogle Scholar
  24. Palm, D., Munch, G., Dees, C. and Hekman, M., 1989, Mapping of -adrenoceptor coupling domains to Gs-protein by site-specific synthetic peptides. FEBS Lett, 254:89–93.PubMedCrossRefGoogle Scholar
  25. Rands, E., Candelore, M.R., Cheung, A.H., Strader, C.D. and Dixon, R.A.F., 1990, Mutational analysis of -adrenergic receptor glycosylation: N-linked sugar addition is required for receptor transport, but not function. J. Biol. Chem., (In press).Google Scholar
  26. Sibley, D.R. and Lefkowitz, R.J., 1987, Molecular mechanisms of receptor desensitization using the -adrenergic receptor-coupled adenylate cyclase system as a model. Nature, 317:124–129.CrossRefGoogle Scholar
  27. Strader, C.D., Sigal, I.S., Register, R.B., Candelore, M.R., Rands, E., and Dixon, R.A.F., 1987a, Identification of residues required for ligand binding to the -adrenergic receptor. Proc. Natl. Acad. Sci., 84:4384–4388.PubMedCrossRefGoogle Scholar
  28. Strader, C.D., Dixon, R. A. F., Cheung, A. H., Candelore, M. R., Blake, A.D., and Sigal, I.S., 1987b Mutations that uncouple the -adrenergic receptor from Gs and increase agonist affinity. J. Biol. Chem., 262:16439–16443.PubMedGoogle Scholar
  29. Strader, C.D., Sigal, I.S., Blake, A.D., Cheung, A.H., Register, R.B., Rands, E., Candelore, M.R., and Dixon, R.A.F., 1987c, The carboxyl terminus of the hamster -adrenergic receptor expressed in mouse L-cells is not required for receptor sequestration. Cell, 49:855–863.PubMedCrossRefGoogle Scholar
  30. Strader, C.D., Sigal, I.S., Candelore, M.R., Rands, E., Hill, W.S., and Dixon, R.A.F., 1988, Conserved aspartic acid residues 79 and 113 of the -adrenergic receptor have different roles in receptor function. J. Biol Chem, 263:10267–10271.PubMedGoogle Scholar
  31. Strader, C.D., Sigal, I.S., and Dixon, R.A.F., 1989a, Structural basis of -adrenergic receptor function. FASEB J, 3:1825–1832.Google Scholar
  32. Strader, C.D., Candelore, M.R., Hill, W.S., Sigal, I.S., and Dixon, R.A.F., 1989b, Identification of two serine residues involved in agonist activation of the-adrenergic receptor.J. Biol. Chem.264:13572–13578.PubMedGoogle Scholar
  33. Wang, H.-Y., Lipfert, L., Malbon, C.C. and Bahouth, S., 1989, Site-directed anti-peptide antibodies define the topography of the -adrenergic receptor. J. Biol. Chem, 264:14424–14431.PubMedGoogle Scholar
  34. Wilden, G.J., Katial, A., Craft, C., and Shinohara, T., 1986, Sequence analysis of bovine retinal S-antigen. FEBS Letters, 196:23–28.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Catherine D. Strader
    • 1
  • Richard A. F. Dixon
    • 2
  1. 1.Department of BiochemistryMerck Sharp & Dohme Research LaboratoriesRahwayUSA
  2. 2.Department of Molecular BiologyMerck Sharp & Dohme Research LaboratoriesWest PointUSA

Personalised recommendations